source
- STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeawaysHere is some of what you may have missed from the world's largest cancer research meeting.STAT · 1mo ago↗ source
- STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to griefAt the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.STAT · 1mo ago↗ source
- The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that wayHow much is a regulatory shortcut worth? The cost of a priority review voucher, which shortens the FDA’s standard review time by about four months, has roughly doubled in the last few years. The FD…Endpoints · 1mo ago↗ source